Cell Biotech Co., Ltd. (KOSDAQ:049960)
13,250
-180 (-1.34%)
At close: Jan 28, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 90.34 billion as of January 29, 2026. Its market cap has decreased by -9.03% in one year.
Market Cap
90.34B
Enterprise Value
1.96B
Revenue
50.65B
Ranking
n/a
PE Ratio
7.18
Stock Price
13,250.00
Market Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 90.34B, an increase of 546.76%. That is a compound annual growth rate of 8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 90.34B | 0.69% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 114.57B |
| CTCBIO | 106.87B |
| Progen | 99.32B |
| IMGT Co.,Ltd. | 97.93B |
| Choong Ang Vaccine Laboratory | 90.33B |
| Naturalendo Tech | 90.30B |
| Shaperon | 89.34B |
| Quratis | 86.53B |